glp-1 weight loss non diabetic list Compare Options | Ozempic v Mounjaro | WeightWatchers Semaglutide for Non-Diabetics: A Guide

The clinical evidence base for combining GLP-1 receptor agonists like Rybelsus with DPP-4 inhibitors such as Januvia is limited and generally does not support this combination as a routine therapeutic strategy

In Phase 2 trials involving participants with type 2 diabetes, HbA1c improved by up to 2.2%, with 82% of participants reaching HbA1c levels at or below 6.5%

But long-term success on Ozempic, Wegovy, or Mounjaro depends far more on preserving muscle than simply burning calories

For information on low-dose aspirin (75-150mg) while breastfeeding please see our factsheet on cardiovascular disease and the circulatory system

& Blumberg, P

December 20, 2023